Comparison between Remimazolam and Dexmedetomidine in patients undergoing Monitored Anesthesia Care for cataract surgery.

UMIN ID: UMIN000055546

Registered date:19/10/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: cataract surgery, Monitoreed Anestehsia Care
• Date of first enrollment: 2024/09/22
• Target sample size: 104
• Countries of recruitment: Asia(except Japan)
• Study type: Interventional

Intervention(s)

Dexmedetomidine
Remimazolam

Outcome(s)

• Primary Outcome: Recovery time after MAC (time required to achieve a PADS score of 9 or higher)
• Secondary Outcome: Patient Satisfaction and Surgeon Satisfaction Vital Signs: Blood pressure, heart rate, oxygen saturation (during anesthesia, post-anesthesia) Type and Dosage of Medications Used: Anesthetics, vasopressors, others Anesthesia Recovery Record Vital Signs During Anesthesia and Recovery: Blood pressure, heart rate, oxygen saturation Recovery Profile Adverse Effects: Nausea/vomiting, apnea, hypotension, arrhythmia, hypoxemia, conversion of anesthesia method, unplanned hospital admission, use of vasopressors

Key inclusion & exclusion criteria

• Age minimum: 19years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: ASA class 4 or higher Pregnant women Patients with preexisting renal or hepatic dysfunction Patients with severe heart failure or coronary artery disease requiring treatment Patients with known drug hypersensitivity to dexmedetomidine or remimazolam Patients who do not consent to participate in this study Patients with limited ability to understand and complete the study consent form and questionnaires

Related Information

• Primary Sponsor: Seoul National University Bundang Hospital
• Source(s) of Monetary Support: Seoul National University Bundang Hospital